Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Steven Shallcross Named Chief Financial Officer of Synthetic Biologics

— Executive Brings Significant Biotech Industry Leadership Experience to Team as Company Enters Next Phase of Development — For Immediate Release Rockville, MD, May 4, 2015 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of pathogen-specific therapeutics focused on protecting the microbiome, as well as treating other diseases, announced Steven A. Shallcross has been […]

Read More »

As Hampton Takes Over as Chairman at GlaxoSmithKline (GSK), CEO Witty Needs to Deliver or “Step Aside”

GlaxoSmithKline (GSK) is under scrutiny Tuesday, after more analysts have called for its longstanding chief executive, Sir Andrew Witty, to either step up his performance or resign within the next year, as the company prepares to receive its new chairman later this week. “Mr. Witty is running out of time,” said Stephen Bailey, a fund […]

Read More »

Thoratec Announces Addition To Senior Management Team

PLEASANTON, Calif., May 1, 2015 /PRNewswire/ — Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that Marta Antonucci has joined Thoratec in the newly created role of President, International. This new Europe-based position is responsible for all Thoratec commercial operations outside of North […]

Read More »

Horizon Pharma plc Names John B. Thomas Executive Vice President, Strategy and Investor Relations

DUBLIN, IRELAND–(Marketwired – May 1, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today named John B. Thomas executive vice president, strategy and investor relations, reporting directly to Timothy P. Walbert, chairman, president and […]

Read More »

Intertek Vice President of Chemical Services Sherri Bassner Joins Board of Industrial Research Institute

CHICAGO–(BUSINESS WIRE)–Intertek (LSE: ITRK), a leading provider of quality and safety services to a wide range of industries around the world, today announced that Sherri Bassner has been elected to the board of directors of the Industrial Research Institute (IRI). She joined the 12-member board yesterday during an official initiation at IRI’s Annual Meeting in […]

Read More »

Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors

Dublin, Ireland– April 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Jeff Poulton as Chief Financial Officer (CFO) and member of the Executive Committee. Jeff will additionally join the Shire Board of Directors. Both appointments are effective immediately.  Jeff has served as Interim CFO since December 2014, while overseeing Investor […]

Read More »

Novo Nordisk’s CEO hopeful quits, chief stays on for stability

(Reuters) – Novo Nordisk’s chief operating officer, a 26-year company veteran who had been expected to become CEO, quit unexpectedly after the board said the current chief should stay until 2019. Chief Executive Lars Rebien Sorensen had been expected to step down from the world’s largest insulin maker well before the end of his contract […]

Read More »

Sorrento Announces the Appointments of David H. Deming to the Board of Directors and Mark W. Durand as Chief Financial Officer

SAN DIEGO, April 30, 2015 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, announced the appointments of David H. Deming to its Board of Directors and Mark W. Durand as Chief Financial Officer.  Mr. Deming replaced Mr. Durand as a member of […]

Read More »

Alexza Pharmaceuticals Announces Management Promotions

MOUNTAIN VIEW, Calif., April 29, 2015 /PRNewswire/ — Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced two management promotions.  Dr. Edwin S. Kamemoto has been promoted to the newly created position of Executive Vice President, R&D and Quality.  In this new role,  Dr. Kamemoto will be responsible for research and development, regulatory affairs, clinical research, pharmacovigilance, and the […]

Read More »

Galderma Announces Two New Senior Leadership Positions

FORT WORTH, Texas, April 28, 2015 /PRNewswire/ — Galderma, the company dedicated to skin health, announces two new leadership appointments today. Kelly Huang, Ph.D. will join Galderma as Vice President and General Manager of the company’s Aesthetic and Corrective Business Unit in the United States. Chuck Paschke was named Senior Director of Organizational Health. Paschke […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom